Cargando…

Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome

Mesenchymal stromal cells (MSCs) possess profound immunomodulatory and regenerative properties that are of clinical use in numerous clinical indications with unmet medical need. Common sources of MSCs include among others, bone marrow (BM), fat, umbilical cord, and placenta-derived decidua stromal c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ringdén, Olle, Moll, Guido, Gustafsson, Britt, Sadeghi, Behnam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973075/ https://www.ncbi.nlm.nih.gov/pubmed/35371003 http://dx.doi.org/10.3389/fimmu.2022.839844

Ejemplares similares

Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease
por: Ringdén, Olle, et al.
Publicado: (2020)

Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review
por: Sadeghi, Behnam, et al.
Publicado: (2022)

Placenta‐Derived Decidua Stromal Cells for Treatment of Severe Acute Graft‐Versus‐Host Disease
por: Ringden, Olle, et al.
Publicado: (2018)

Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis
por: Baygan, Arjang, et al.
Publicado: (2017)

Novel therapies for graft versus host disease with a focus on cell therapies
por: Zeiser, Robert, et al.
Publicado: (2023)

Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells
por: Sadeghi, Behnam, et al.
Publicado: (2019)

Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells
por: Sadeghi, Behnam, et al.
Publicado: (2019)

Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model
por: Fernández-García, María, et al.
Publicado: (2015)

Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease
por: Lin, Yan, et al.
Publicado: (2023)

Adipose tissue-derived human mesenchymal stromal cells can better suppress complement lysis, engraft and inhibit acute graft-versus-host disease in mice
por: Wu, Stanley Chun Ming, et al.
Publicado: (2023)

Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses
por: Moll, Guido, et al.
Publicado: (2011)

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020)

Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
por: Kelly, Kilian, et al.
Publicado: (2021)

Fetal liver-derived mesenchymal stromal cells augment engraftment of transplanted hepatocytes
por: Joshi, Meghnad, et al.
Publicado: (2012)

Engraftment Outcomes after HPC Co-Culture with Mesenchymal Stromal Cells and Osteoblasts
por: Cook, Matthew M., et al.
Publicado: (2013)

Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease
por: Krüger, Thomas, et al.
Publicado: (2022)

Mesenchymal stem/stromal cells enhance engraftment, vasculogenic and pro-angiogenic activities of endothelial colony forming cells in immunocompetent hosts
por: Shafiee, Abbas, et al.
Publicado: (2017)

Roles of Host Nonhematopoietic Cells in Autoimmunity and Donor Cell Engraftment in Graft-versus-host Disease
por: Kim, Juyang, et al.
Publicado: (2010)

Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults
por: Poiret, Thomas, et al.
Publicado: (2014)

Posttransplant Intramuscular Injection of PLX-R18 Mesenchymal-Like Adherent Stromal Cells Improves Human Hematopoietic Engraftment in A Murine Transplant Model
por: Metheny, Leland, et al.
Publicado: (2018)

Systemic lupus erythematosus in a 15-year-old with graft-versus-host disease following liver transplant and unexpected full hematopoietic engraftment
por: Goeser, Laura E., et al.
Publicado: (2022)

Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation
por: Poiret, Thomas, et al.
Publicado: (2018)

The Role of T Cells in Hematopoietic Stem Cell Engraftment
por: Hexner, Elizabeth
Publicado: (2006)

Conquering the cytokine storm in COVID‐19‐induced ARDS using placenta‐derived decidua stromal cells
por: Sadeghi, Behnam, et al.
Publicado: (2021)

Conquering the Cytokine Storm in COVID-19 Induced ARDS Using Placenta-Derived Decidua Stromal Cells
por: Ringden, Olle, et al.
Publicado: (2022)

Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes
por: Keyzner, Alla, et al.
Publicado: (2023)

Heparanase Promotes Engraftment and Prevents Graft versus Host Disease in Stem Cell Transplantation
por: Bitan, Menachem, et al.
Publicado: (2010)

Adult human mesenchymal stromal cells and the treatment of graft versus host disease
por: Herrmann, Richard P, et al.
Publicado: (2014)

Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?
por: Dunavin, Neil, et al.
Publicado: (2017)

Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
por: Cheung, Tik Shing, et al.
Publicado: (2020)

Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease
por: Godoy, Juliana A. P., et al.
Publicado: (2019)

Current perspectives on mesenchymal stromal cell therapy for graft versus host disease
por: Kadri, Nadir, et al.
Publicado: (2023)

Pre-engraftment Syndrome in Hematopoietic Stem Cell Transplantation
por: Lee, Young-Ho, et al.
Publicado: (2008)

Quickly attainable and highly engrafting hematopoietic stem cells
por: Broxmeyer, Hal E.
Publicado: (2019)

PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice
por: Yin, Xiuxiu, et al.
Publicado: (2019)

How mesenchymal stem cell cotransplantation with hematopoietic stem cells can improve engraftment in animal models
por: Garrigós, Murilo Montenegro, et al.
Publicado: (2022)

Harnessing and honing mesenchymal stem/stromal cells for the amelioration of graft-versus-host disease
por: Jaing, Tang-Her, et al.
Publicado: (2023)

In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome
por: Simonson, Oscar E., et al.
Publicado: (2016)

Correction: PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice
por: Yin, Xiuxiu, et al.
Publicado: (2020)

Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning
por: Bhattacharya, Deepta, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_vkbmbsf2dabu3qr28h5gq2f81v